Income Tax (Details) $ in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2021
USD ($)
| |
| Income Tax (Details) [Line Items] | |
| Corporate tax rates | 23.00% |
| Net carry forward tax losses | $ 54,807 |
| CollPlant Biotechnologies Ltd [Member] | |
| Income Tax (Details) [Line Items] | |
| Net carry forward tax losses | $ 7,761 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|